Cargando…

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer

Oestrogen receptor-binding fragment associated gene 9, EBAG9, is an oestrogen-responsive gene that was identified in MCF-7 human breast carcinoma cell line. It is identical to RCAS 1, a cancer cell surface antigen possibly involved in immune escape. In the present study, we examined the expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akahira, J-i, Aoki, M, Suzuki, T, Moriya, T, Niikura, H, Ito, K, Inoue, S, Okamura, K, Sasano, H, Yaegashi, N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409481/ https://www.ncbi.nlm.nih.gov/pubmed/15164121 http://dx.doi.org/10.1038/sj.bjc.6601832

Ejemplares similares

EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine–immune interactions
por: Suzuki, T, et al.
Publicado: (2001)

Association between RCAS1 expression and clinical outcome in uterine endometrial cancer
por: Sonoda, K, et al.
Publicado: (2003)

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies
por: Akahira, J, et al.
Publicado: (2000)

Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
por: Reimer, Tatiana A, et al.
Publicado: (2005)

Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
por: Akahira, Jun‐Ichi, et al.
Publicado: (2001)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
por: Rask, K, et al.
Publicado: (2003)

Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003)

Differential Expression of Progesterone Receptor Isoforms A and B in the Normal Ovary, and in Benign, Borderline, and Malignant Ovarian Tumors
por: Akahira, Jun‐ichi, et al.
Publicado: (2002)

c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells
por: Sheen, J-H, et al.
Publicado: (2003)

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
por: Lassus, H, et al.
Publicado: (2004)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

Characterisation of human kallikrein 6/protease M expression in ovarian cancer
por: Ni, X, et al.
Publicado: (2004)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
por: Wang, Y, et al.
Publicado: (2004)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells
por: Zhang, X, et al.
Publicado: (2004)

Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
por: Dent, J, et al.
Publicado: (2003)

Purified malignant mammary epithelial cells maintain hormone responsiveness in culture
por: Kothari, M S, et al.
Publicado: (2003)

Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma
por: Ogawa, K, et al.
Publicado: (2004)

Allelic loss at 19q12 and Xq11–12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential
por: Nakayama, K, et al.
Publicado: (2004)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer
por: Ahmed, N, et al.
Publicado: (2004)

Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women
por: Molano, M, et al.
Publicado: (2002)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid
por: Ito, Y, et al.
Publicado: (2002)

Expression of cdc25A and cdc25B proteins in thyroid neoplasms
por: Ito, Y, et al.
Publicado: (2002)

The human ovarian surface epithelium is an androgen responsive tissue
por: Edmondson, R J, et al.
Publicado: (2002)

Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer
por: Benoy, I H, et al.
Publicado: (2004)

Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions
por: Chatrath, P, et al.
Publicado: (2003)

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
por: Junnikkala, S, et al.
Publicado: (2002)

Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype
por: Kawaguchi, K, et al.
Publicado: (2004)

Predicting biomarkers for ovarian cancer using gene-expression microarrays
por: Adib, T R, et al.
Publicado: (2004)

Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression
por: White, S L, et al.
Publicado: (2004)

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth
por: Kaneko, K, et al.
Publicado: (2004)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens
por: Scott, I S, et al.
Publicado: (2004)

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ka3fr20shlhije9m23f14h2k9e